• Empowering Wellness...

Enhertu 100mg Injection in Maldives

Enhertu 100mg Injection

SKU: ENHERTU-100MG-INJECTION
$1,779.03$1,464.17
CategoriesAnti-Cancer
Manufacturer/Marketed ByASTRAZENECA PHARMA INDIA LTD
Inquiry on WhatsApp

Active Pharmaceutical Ingredient

TRASTUZUMAB DERUXTECAN

Product Information

Enhertu 100mg Injection is a pharmaceutical product available for international pharmaceutical supply. Siddha Global is an India-based pharmaceutical exporter serving international buyers, importers, distributors and pharmaceutical companies.

We accept enquiries for Enhertu 100mg Injection for Maldives, subject to product availability and applicable regulatory and import requirements.

For pricing, availability and bulk supply, contact Siddha Global with your required quantity and procurement details.

Enhertu 100mg Injection Supplier for Maldives

Siddha Global supplies pharmaceutical products to international markets and accepts enquiries from qualified pharmaceutical buyers in the Maldives.

We work with:

  • Pharmaceutical importers
  • Pharmaceutical distributors
  • Pharmaceutical wholesalers
  • Hospitals and healthcare organizations
  • Pharmaceutical companies
  • Authorized procurement organizations

Buyers can contact us for Enhertu 100mg Injection availability, pricing and bulk supply requirements.

Buy Enhertu 100mg Injection for Maldives

If you are looking to source Enhertu 100mg Injection in Maldives, send us your requirements.

Please provide:

  • Required quantity
  • Product name and strength
  • Destination country: Maldives
  • Packaging requirements
  • Delivery requirements

Our team will review your enquiry and provide relevant product and commercial information.

Why Choose Siddha Global?

Pharmaceutical Exporter from India

Siddha Global is an India-based pharmaceutical exporter supplying pharmaceutical products to international markets.

International Pharmaceutical Supply

We support pharmaceutical sourcing requirements for importers, distributors and other qualified international buyers.

Bulk Pharmaceutical Orders

We accept enquiries for bulk pharmaceutical requirements based on product availability and applicable market requirements.

Export Support

We assist international buyers with relevant commercial and export requirements for pharmaceutical orders.

Frequently Asked Questions

What is Enhertu 100mg Injection?

Enhertu 100mg Injection is a pharmaceutical product supplied in a 100mg strength for international pharmaceutical sourcing.

Is Enhertu 100mg Injection available in Maldives?

Siddha Global accepts enquiries for Enhertu 100mg Injection supply to Maldives, subject to product availability and applicable Maldivian regulatory and import requirements.

What is the strength of Enhertu Injection?

Enhertu Injection is available in a 100mg strength.

Can I order Enhertu 100mg Injection in bulk?

Yes. Qualified pharmaceutical importers, distributors and other authorized buyers can submit bulk requirements to Siddha Global for availability and commercial information.

How can I request a quotation for Enhertu 100mg Injection?

Send us your required quantity, destination country and packaging requirements. Our team can review your enquiry and provide relevant quotation information.

Who can enquire about Enhertu 100mg Injection?

Pharmaceutical importers, distributors, wholesalers, healthcare organizations and other appropriately authorized organizations can contact Siddha Global regarding pharmaceutical procurement.

Request a Quote for Enhertu 100mg Injection

Looking for Enhertu 100mg Injection in Maldives?

Contact Siddha Global for product availability, pricing and bulk pharmaceutical supply enquiries.

• Treats HER2-positive breast cancer that is metastatic or unresectable for patients who have had prior anti-HER2 treatments. • Effective for HER2-low metastatic breast cancer after prior chemotherapy. • Treats HER2-mutated non-small cell lung cancer (NSCLC) that is metastatic or unresectable following prior treatment. • Used for HER2-positive gastric or gastroesophageal junction (GEJ) adenocarcinoma after prior trastuzumab-based therapy. • For HER2-positive (IHC 3+) metastatic solid tumours when no other satisfactory treatments are available.

Enhertu 100mg Injection is used in the treatment of certain types of breast and gastric cancers that express specific proteins. It works as a targeted therapy by delivering a potent anti-cancer agent directly to cancer cells, helping to destroy them while limiting damage to healthy cells. By targeting cancer more precisely, it helps slow down disease progression and may reduce tumor size. This medicine can also help relieve symptoms associated with cancer, supporting better overall health. Regular use as prescribed improves treatment response and enhances quality of life.

Enhertu 100mg Injection Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.

• Nausea (feeling sick), vomiting • Tiredness • Decreased appetite • Blood tests showing decreased red or white blood cells or platelets • Hair loss • Diarrhoea • Constipation • Blood tests showing increased levels of the liver enzymes such as transaminases • Pain in muscles and bones • Weight loss • Fever • Abdominal (belly) pain • Infections of the nose and throat, including flu-like symptoms • Headache • Blisters in or around your mouth • Cough • Blood tests showing low blood potassium levels • Indigestion • Breathing difficulties • Swelling of ankles and feet • Nosebleed • Altered/bad taste in the mouth • Infection of the lungs

Enhertu 100mg Injection is administered through an intravenous (IV) infusion by a healthcare provider every three weeks. Before each treatment, you may receive medication to prevent nausea and vomiting. If you have an infusion-related reaction, the infusion may be slowed, paused, or permanently stopped for severe reactions. If you miss a dose, it's important to contact your healthcare provider immediately to reschedule. The number of treatments will depend on your healthcare provider's assessment. Your healthcare Provider will decide the Enhertu 100mg dosage and administration.

• Breast Feeding: Enhertu 100mg Injection in nursing mothers has not been studied, and whether it is excreted in breast milk is unknown. Hence, it is not recommended to take this medication in breastfeeding mothers. • Alcohol: Enhertu 100mg Injection is not known to interact with alcohol. However, both Enhertu 100 mg Injection and alcohol can have similar side effects, such as headaches and nausea. Be vigilant about these side effects and contact your doctor for more advice. • Liver: Before beginning treatment with Enhertu 100mg Injection, it is important to let your doctor know if you suffer from liver impairment, as this may necessitate an adjustment in dosage depending on the severity of your liver condition. • Lungs: If you have a history of lung disease, you may be at a higher risk of developing interstitial lung disease when using Enhertu 100mg Injection. Therefore, informing your doctor about any lung issues you have before beginning treatment with this medication is important. • Driving: Enhertu 100mg Injection does not impair your ability to drive or operate machinery. However, be cautious if you feel dizzy, tired, or have a headache. Contact your doctor for more advice. • Pregnancy: Enhertu 100mg Injection, when taken during pregnancy, can cause neonatal complications. Hence, it is not recommended to take this medication if you are pregnant, planning for pregnancy or think you may become pregnant.
Chat with Siddha Global on WhatsApp